Specific and nonspecific rashes associated with antibodies to Ro/SS-A are often related to subacute cutaneous lupus erythematosus (SCLE). Typically, lesions specific to SCLE do not itch and may ...

These include: malar rash − “butterfly rash” that appears on the ... criteria but also emphasize nonscarring alopecia and subacute cutaneous lupus erythematosus (SCLE). The major role that cutaneous ...

under the microscope and may be subacute, chronic and recurrent, persisting from months to years (Arroyo, 2002; Salvarani, 2005). Various other rashes and lesions may also be present (see Figures ...

Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know ...

Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful improvement in disease activity at Week 16 ...

Cohort A focused on patients with CLE or SLE with active lupus rash and evaluated organ-specific disease activity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity ...

AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK ...

The primary endpoint of the study, focusing on patients with CLE or SLE with lupus rash, was met at Week 16, showing a dose-response relationship and a significant improvement in the Cutaneous ...

with active lupus rash. As a prominent player in the pharmaceuticals industry with a market capitalization of $57.6 billion and robust gross margins of 59%, Merck KGaA continues to demonstrate its ...

Cohort A focused on patients with CLE or SLE with active lupus rash and evaluated organ-specific disease activity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity ...